Intervention
Active Comparator
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 11 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
11 shownComparison of Paragastric Nerve Block and Erector Spinae Plane Block on Postoperative Pain After Sleeve GastrectomyNCT07811206 · 2026-10-15
NOT_YET_RECRUITINGPreventing T2DM After GDM With Immediate Postpartum ScreeningNCT06457139 · 2025-06-01
COMPLETEDEvaluation and Treatment for Diabetic Peripheral NeuropathyNCT07317284 · 2024-07-10
COMPLETEDAdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary BehaviorsNCT06257550 · 2024-06-10
COMPLETEDEpidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry DataNCT04572165 · 2021-01-26
COMPLETEDFinancial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1NCT04203173 · 2019-12-01
COMPLETEDEnhancing Systems of Care to Improve Hypertension Guideline ImplementationNCT03563872 · 2019-02-01
WITHDRAWNA Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in HumansNCT02167607 · 2014-06-01
COMPLETEDCharacterization of Wild Blueberry Polyphenols Bioavailability and Kinetic Profile Over 24-hour PeriodNCT02167555 · 2014-06-01
COMPLETEDEffects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple SclerosisNCT02104492 · 2014-03-01
UNKNOWNRandomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)NCT01614886 · 2012-07-01
COMPLETEDCommon conditions
Hypertension2Type 2 Diabetes2Alzheimer's Disease1Diabetes Mellitus, Type 21Diabetic Neuropathy Peripheral1Gestational Diabetes1Healthy1Obese1Obesity Morbid Obesity Postoperative Pain1Obesity Postoperative Pain1Overweight1Overweight and Obese Women1Premenopausal Women1Relapsing-remitting Multiple Sclerosis1
Leading sponsors
Clinical Nutrition Research Center, Illinois Institute of Technology
2
Atlas University
1
Henry Ford Health System
1
Johns Hopkins University
1
Novartis Pharmaceuticals
1
Novo Nordisk A/S
1
State University of New York at Buffalo
1
University of Malaga
1
University of Massachusetts, Worcester
1
University of Sao Paulo
1
Trial status mix
COMPLETED8
NOT_YET_RECRUITING1
UNKNOWN1
WITHDRAWN1
Phase mix
NA9
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.